Publication Information

{'id': 'https://openalex.org/W2415742554', 'doi': 'https://doi.org/10.1136/ejhpharm-2016-000875.178', 'title': 'CP-178 Safety and use of biological treatments etanercept, adalimumab and ustekinumab in psoriasis', 'display_name': 'CP-178 Safety and use of biological treatments etanercept, adalimumab and ustekinumab in psoriasis', 'publication_year': 2016, 'publication_date': '2016-02-14', 'ids': {'openalex': 'https://openalex.org/W2415742554', 'doi': 'https://doi.org/10.1136/ejhpharm-2016-000875.178', 'mag': '2415742554'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1136/ejhpharm-2016-000875.178', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2755127630', 'display_name': 'Clinical pharmacy', 'issn_l': '0278-2677', 'issn': ['0278-2677'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4366067048', 'host_organization_name': 'American Society of Hospital Pharmacists', 'host_organization_lineage': ['https://openalex.org/P4366067048'], 'host_organization_lineage_names': ['American Society of Hospital Pharmacists'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'proceedings-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5091440406', 'display_name': 'Leyre Zúñiga', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210116170', 'display_name': 'Hospital Universitario Virgen de las Nieves', 'ror': 'https://ror.org/02f01mz90', 'country_code': 'ES', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210116170']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'L Gutiérrez Zúñiga', 'raw_affiliation_strings': ['Complejo Hospitalario Universitario Gradana. Hospital Universitario Virgen de Las Nieves, Farmacia Hospitalaria, Granada, Spain'], 'affiliations': [{'raw_affiliation_string': 'Complejo Hospitalario Universitario Gradana. Hospital Universitario Virgen de Las Nieves, Farmacia Hospitalaria, Granada, Spain', 'institution_ids': ['https://openalex.org/I4210116170']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5076676906', 'display_name': 'Miguel Goicoechea', 'orcid': 'https://orcid.org/0000-0003-0721-6528'}, 'institutions': [{'id': 'https://openalex.org/I4210116170', 'display_name': 'Hospital Universitario Virgen de las Nieves', 'ror': 'https://ror.org/02f01mz90', 'country_code': 'ES', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210116170']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'M Rodríguez Goicoechea', 'raw_affiliation_strings': ['Complejo Hospitalario Universitario Gradana. Hospital Universitario Virgen de Las Nieves, Farmacia Hospitalaria, Granada, Spain'], 'affiliations': [{'raw_affiliation_string': 'Complejo Hospitalario Universitario Gradana. Hospital Universitario Virgen de Las Nieves, Farmacia Hospitalaria, Granada, Spain', 'institution_ids': ['https://openalex.org/I4210116170']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103685734', 'display_name': 'MS Caparrós Romero', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210121788', 'display_name': 'Complejo Hospitalario Universitario de Granada', 'ror': 'https://ror.org/02pnm9721', 'country_code': 'ES', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210121788']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'MS Caparrós Romero', 'raw_affiliation_strings': ['Complejo Hospitalario Universitario Granada. Hospital Comarcal de Baza, Farmacia Hospitalaria, Granada, Spain'], 'affiliations': [{'raw_affiliation_string': 'Complejo Hospitalario Universitario Granada. Hospital Comarcal de Baza, Farmacia Hospitalaria, Granada, Spain', 'institution_ids': ['https://openalex.org/I4210121788']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5015297097', 'display_name': 'Mónica Ferrit Martín', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210116170', 'display_name': 'Hospital Universitario Virgen de las Nieves', 'ror': 'https://ror.org/02f01mz90', 'country_code': 'ES', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210116170']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'M Ferrit Martín', 'raw_affiliation_strings': ['Complejo Hospitalario Universitario Gradana. Hospital Universitario Virgen de Las Nieves, Farmacia Hospitalaria, Granada, Spain'], 'affiliations': [{'raw_affiliation_string': 'Complejo Hospitalario Universitario Gradana. Hospital Universitario Virgen de Las Nieves, Farmacia Hospitalaria, Granada, Spain', 'institution_ids': ['https://openalex.org/I4210116170']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5109315814', 'display_name': 'MA Calleja Hernández', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210116170', 'display_name': 'Hospital Universitario Virgen de las Nieves', 'ror': 'https://ror.org/02f01mz90', 'country_code': 'ES', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210116170']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'MA Calleja Hernandez', 'raw_affiliation_strings': ['Complejo Hospitalario Universitario Gradana. Hospital Universitario Virgen de Las Nieves, Farmacia Hospitalaria, Granada, Spain'], 'affiliations': [{'raw_affiliation_string': 'Complejo Hospitalario Universitario Gradana. Hospital Universitario Virgen de Las Nieves, Farmacia Hospitalaria, Granada, Spain', 'institution_ids': ['https://openalex.org/I4210116170']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.384, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.520095, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 66, 'max': 73}, 'biblio': {'volume': None, 'issue': None, 'first_page': 'A78.3', 'last_page': 'A79'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12547', 'display_name': 'Pharmaceutical studies and practices', 'score': 0.9786, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12547', 'display_name': 'Pharmaceutical studies and practices', 'score': 0.9786, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10469', 'display_name': 'Psoriasis: Treatment and Pathogenesis', 'score': 0.966, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/ustekinumab', 'display_name': 'Ustekinumab', 'score': 0.95560217}], 'concepts': [{'id': 'https://openalex.org/C2780132546', 'wikidata': 'https://www.wikidata.org/wiki/Q348260', 'display_name': 'Adalimumab', 'level': 3, 'score': 0.9623032}, {'id': 'https://openalex.org/C2778975655', 'wikidata': 'https://www.wikidata.org/wiki/Q420305', 'display_name': 'Ustekinumab', 'level': 4, 'score': 0.95560217}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.92615557}, {'id': 'https://openalex.org/C2777226972', 'wikidata': 'https://www.wikidata.org/wiki/Q415343', 'display_name': 'Etanercept', 'level': 3, 'score': 0.90134907}, {'id': 'https://openalex.org/C2780564577', 'wikidata': 'https://www.wikidata.org/wiki/Q179945', 'display_name': 'Psoriasis', 'level': 2, 'score': 0.65860707}, {'id': 'https://openalex.org/C23131810', 'wikidata': 'https://www.wikidata.org/wiki/Q818574', 'display_name': 'Observational study', 'level': 2, 'score': 0.63660926}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.57248473}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.46404192}, {'id': 'https://openalex.org/C535046627', 'wikidata': 'https://www.wikidata.org/wiki/Q30612', 'display_name': 'Clinical trial', 'level': 2, 'score': 0.44502544}, {'id': 'https://openalex.org/C2777011040', 'wikidata': 'https://www.wikidata.org/wiki/Q390643', 'display_name': 'Psoriasis Area and Severity Index', 'level': 3, 'score': 0.4391192}, {'id': 'https://openalex.org/C16005928', 'wikidata': 'https://www.wikidata.org/wiki/Q171171', 'display_name': 'Dermatology', 'level': 1, 'score': 0.2930754}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.13720247}, {'id': 'https://openalex.org/C17991360', 'wikidata': 'https://www.wikidata.org/wiki/Q21173843', 'display_name': 'Tumor necrosis factor alpha', 'level': 2, 'score': 0.084610224}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1136/ejhpharm-2016-000875.178', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2755127630', 'display_name': 'Clinical pharmacy', 'issn_l': '0278-2677', 'issn': ['0278-2677'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4366067048', 'host_organization_name': 'American Society of Hospital Pharmacists', 'host_organization_lineage': ['https://openalex.org/P4366067048'], 'host_organization_lineage_names': ['American Society of Hospital Pharmacists'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.83}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4398222403', 'https://openalex.org/W2980843199', 'https://openalex.org/W2944747466', 'https://openalex.org/W2943915314', 'https://openalex.org/W2766130161', 'https://openalex.org/W2236197927', 'https://openalex.org/W2162495586', 'https://openalex.org/W2075153701', 'https://openalex.org/W2048986416', 'https://openalex.org/W2019435110'], 'abstract_inverted_index': {'<h3>Background</h3>': [0], 'The': [1, 289, 330, 351], 'safety': [2, 34, 45], 'of': [3, 9, 24, 48, 56, 73, 104, 124, 131, 146, 163, 191, 221, 240, 269, 279, 333, 348, 365], 'biologic': [4], 'agents': [5], 'for': [6, 119, 129, 294, 359], 'the': [7, 30, 44, 267, 311, 324], 'treatment': [8, 57, 149, 343], 'psoriasis': [10, 61, 74, 295], 'has': [11], 'been': [12], 'studied': [13], 'in': [14, 36, 53, 58, 266, 296, 316, 338], 'long': [15], 'term': [16], 'clinical': [17, 107, 132], 'trials': [18], 'with': [19, 60, 150, 154, 159, 243, 255, 263, 282], 'up': [20, 101], 'to': [21, 32, 81, 102], '5': [22], 'years': [23], 'follow-up.': [25], 'However,': [26], 'observational': [27, 70], 'studies': [28], 'provide': [29], 'potential': [31], 'identify': [33], 'signals': [35], 'a': [37, 63, 166, 194, 345], 'real': [38], 'world': [39], 'setting.': [40], '<h3>Purpose</h3>': [41], 'To': [42], 'evaluate': [43], 'and': [46, 51, 67, 95, 106, 122, 127, 157, 183, 211, 233, 235, 259, 261, 271, 306, 318], 'use': [47], 'adalimumab,': [49], 'etanercept': [50, 155, 180, 208, 244, 307, 339], 'ustekinumab': [52, 160, 187, 215, 283, 304, 322], 'several': [54], 'lines': [55], 'patients': [59, 75, 136, 147, 164, 172, 178, 185, 192, 200, 206, 213, 222, 241, 250, 280], 'from': [62, 77], 'tertiary': [64], 'hospital.': [65], '<h3>Material': [66], 'methods</h3>': [68], 'Retrospective': [69], 'longitudinal': [71], 'study': [72], 'followed': [76, 302], '1': [78, 272], 'January': [79], '2008': [80], '30': [82], 'June': [83], '2015;': [84], 'there': [85], 'were': [86, 114, 137], 'no': [87], 'exit': [88], 'points.': [89], 'Variables': [90], 'included': [91, 138], 'were:': [92], 'demographic': [93], '(sex': [94], 'age),': [96], 'pharmacological': [97, 125], '(biological': [98], 'drug': [99, 169, 197, 293, 312], 'used': [100, 113, 291, 315, 327], 'thirdline': [103, 319], 'treatment)': [105], '(side': [108], 'effects': [109, 228, 335], 'reported).': [110], 'Clinical': [111], 'databases': [112], 'PRISMA': [115], '(prescribing': [116], 'electronic': [117], 'software)': [118], 'patient': [120, 230, 273], 'selection': [121], 'collection': [123, 130], 'variables,': [126], 'DIRAYA': [128], 'variables.': [133], '<h3>Results</h3>': [134], '88': [135], '(mean': [139], 'age': [140], '66': [141], 'years;': [142], '60%': [143], 'males).': [144], '40%': [145], 'started': [148], 'adalimumab': [151, 174, 202, 224, 300, 342], '(35/88),': [152], '31%': [153], '(27/88)': [156], '29%': [158], '(26/88).': [161], '42%': [162], 'required': [165, 193], 'second': [167], 'biological': [168, 196, 292, 361], '(37/88).': [170], '9': [171], 'received': [173, 179, 186, 201, 207, 214], '(9/37;': [175], '24%),': [176], '6': [177], '(6/37;': [181], '16%)': [182], '22': [184], '(22/37;': [188], '60%).': [189], '16%': [190], 'third': [195], '(14/88).': [198], '8': [199], '(8/14;': [203], '57%),': [204], '4': [205, 249], '(4/14;': [209], '29%)': [210], '2': [212], '(2/14;': [216], '14%).': [217], 'Regarding': [218], 'safety,': [219], '4%': [220], 'receiving': [223], '(2/53)': [225], 'experienced': [226, 246, 284], 'adverse': [227, 334, 349, 354], '(one': [229], 'presented': [231, 344], 'fatigue': [232], 'headaches': [234], 'other': [236, 262], 'increased': [237, 252, 285, 357], 'transaminases).': [238], '14%': [239], 'treated': [242, 281], '(5/37)': [245], 'side': [247], 'effects:': [248], 'showed': [251, 274], 'transaminases': [253, 286, 358], '(1': [254], 'concomitant': [256, 264], 'anxious': [257], 'depression': [258], 'tonsillitis,': [260], 'discomfort': [265], 'area': [268], '\u200b\u200binjection),': [270], 'herpes': [275], 'simplex': [276], 'reactivation.': [277], '6%': [278], '(3/50).': [287], '<h3>Conclusion</h3>': [288], 'most': [290, 313, 325, 352], 'our': [297], 'hospital': [298], 'was': [299, 310, 323, 336, 356], '(60%),': [301], 'by': [303], '(56%)': [305], '(42%).': [308], 'Adalimumab': [309], 'commonly': [314, 326], 'first': [317], 'treatment,': [320], 'whereas': [321, 341], 'secondline': [328], 'drug.': [329], 'highest': [331], 'percentage': [332], 'found': [337], 'patients,': [340], 'lower': [346], 'occurrence': [347], 'events.': [350], 'common': [353], 'effect': [355], 'any': [360], 'therapy.': [362], 'No': [363], 'conflict': [364], 'interest.': [366]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2415742554', 'counts_by_year': [{'year': 2017, 'cited_by_count': 1}], 'updated_date': '2024-12-08T15:20:04.673521', 'created_date': '2016-06-24'}